Deepa H. Chand

Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry

Scott M. Sutherland, Michael Zappitelli, Steven R. Alexander et al. · American Journal of Kidney Diseases · 2009 · 691 citations

Medicine, Nephrology, Pediatrics +12

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial

Richard S. Finkel, Claudia A. Chiriboga, Anne M. Connolly et al. · The Lancet Neurology · 2021 · 480 citations

Medicine, Genetics, Molecular Genetics +14

Demographic Characteristics of Pediatric Continuous Renal Replacement Therapy

Jordan M. Symons, Annabelle N. Chua, Michaël Somers et al. · Clinical Journal of the American Society of Nephrology · 2007 · 299 citations

Medicine, Nephrology, Pediatrics +12

Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy

Deepa H. Chand, F. Mohr, Hugh J. McMillan et al. · Journal of Hepatology · 2020 · 297 citations · Full text

Medicine, Pharmacology, Toxicology +17

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello et al. · The Lancet Neurology · 2021 · 256 citations

Medicine, Neurology, Neuroscience +12